Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Dermatologic Clinics
|
October 5, 2015
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma
Auris O Huen, Ellen J Kim
Current Opinion in Oncology
|
January 21, 2014
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma
Auris O Huen, Alain H Rook
JAAD Case Reports
|
July 31, 2025
Primary cutaneous anaplastic large cell lymphoma: Clinical response with low dose brentuximab vedotin on a patient receiving hemodialysis
Claire Fason, Stephen Tyring, Auris O Huen
SAGE Open Medical Case Reports
|
September 15, 2018
A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report
Alexander B Aria, Leon Chen, Auris O Huen
Archives of Dermatological Research
|
November 29, 2019
Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients
Drew A Emge, Roland L Bassett, Madeleine Duvic, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2021
Health-related quality of life effect of mogamulizumab by patient blood involvement
Pier Luigi Zinzani, Pablo Ortiz-Romero, Margarida Lima, et al.
Dermatology Online Journal
|
July 5, 2020
Unusual presentation of Kaposi sarcoma in an HIV-negative woman
Allison L Limmer, Katherine E Park, Anisha B Patel, et al.
JAMA Dermatology
|
October 6, 2017
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results
Daniel J Lewis, Rakhshandra Talpur, Auris O Huen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 14, 2021
Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients
Jonathan J Lo, Meghan M Heberton, Omar Pacha, et al.
JAAD International
|
August 18, 2023
Management strategies and survival in cutaneous B-cell lymphoma: A population based study
Kyle Lauck, Areebah S Ahmad, Quoc-Bao D Nguyen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Dermatologic Clinics
|
October 5, 2015
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma
Auris O Huen, Ellen J Kim
Current Opinion in Oncology
|
January 21, 2014
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma
Auris O Huen, Alain H Rook
JAAD Case Reports
|
July 31, 2025
Primary cutaneous anaplastic large cell lymphoma: Clinical response with low dose brentuximab vedotin on a patient receiving hemodialysis
Claire Fason, Stephen Tyring, Auris O Huen
SAGE Open Medical Case Reports
|
September 15, 2018
A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report
Alexander B Aria, Leon Chen, Auris O Huen
Archives of Dermatological Research
|
November 29, 2019
Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients
Drew A Emge, Roland L Bassett, Madeleine Duvic, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2021
Health-related quality of life effect of mogamulizumab by patient blood involvement
Pier Luigi Zinzani, Pablo Ortiz-Romero, Margarida Lima, et al.
Dermatology Online Journal
|
July 5, 2020
Unusual presentation of Kaposi sarcoma in an HIV-negative woman
Allison L Limmer, Katherine E Park, Anisha B Patel, et al.
JAMA Dermatology
|
October 6, 2017
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results
Daniel J Lewis, Rakhshandra Talpur, Auris O Huen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 14, 2021
Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients
Jonathan J Lo, Meghan M Heberton, Omar Pacha, et al.
JAAD International
|
August 18, 2023
Management strategies and survival in cutaneous B-cell lymphoma: A population based study
Kyle Lauck, Areebah S Ahmad, Quoc-Bao D Nguyen, et al.
Page
of 3